MANGALAM GLOBAL ENTERPRISE
Back to Balance Sheet
|
MANGALAM GLOBAL ENTERPRISE Last 5 Year Total Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹549 Cr | ₹405 Cr | ₹422 Cr | ₹270 Cr | ₹221 Cr |
What is the latest Total Liabilities ratio of MANGALAM GLOBAL ENTERPRISE ?
| Year | Total Liabilities |
|---|---|
| Mar2025 | ₹549 Cr |
| Mar2024 | ₹405 Cr |
| Mar2023 | ₹422 Cr |
| Mar2022 | ₹270 Cr |
| Mar2021 | ₹221 Cr |
How is Total Liabilities of MANGALAM GLOBAL ENTERPRISE Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹549 Cr | 35.50 | |
| Mar2024 | ₹405 Cr | -4.02 | |
| Mar2023 | ₹422 Cr | 56.03 | |
| Mar2022 | ₹270 Cr | 22.36 | |
| Mar2021 | ₹221 Cr | - | |
Compare Total Liabilities of peers of MANGALAM GLOBAL ENTERPRISE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MANGALAM GLOBAL ENTERPRISE | ₹447.9 Cr | -3.8% | 30.1% | -2.8% | Stock Analytics | |
| BOMBAY BURMAH TRADING CORPORATION | ₹10,445.5 Cr | -0.8% | -0.4% | -19.7% | Stock Analytics | |
| KAVERI SEED COMPANY | ₹4,837.8 Cr | 0.8% | 15.6% | -39.3% | Stock Analytics | |
| VENKYS (INDIA) | ₹2,138.0 Cr | -4.1% | 16.4% | -9.3% | Stock Analytics | |
| BOMBAY SUPER HYBRID SEEDS | ₹1,071.5 Cr | 2.2% | 30.2% | -36% | Stock Analytics | |
| INDO US BIOTECH | ₹205.4 Cr | -4.8% | -2.6% | -39.4% | Stock Analytics | |
MANGALAM GLOBAL ENTERPRISE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MANGALAM GLOBAL ENTERPRISE | -3.8% |
30.1% |
-2.8% |
| SENSEX | -2.3% |
3.3% |
-2.4% |
You may also like the below Video Courses